XBIOTECH INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
XBIOTECH INC. (XBIT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -5.80% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2025-03-18
- XBIOTECH INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2024 was -5.80%.
- XBIOTECH INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2023 was -6.80%.
- XBIOTECH INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2022 was -5.80%.
- XBIOTECH INC. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2021 was -3.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|
| 2024-12-31 | -5.80% 10-K · filed 2025-03-18 |
| 2023-12-31 | -6.80% 10-K · filed 2025-03-18 |
| 2022-12-31 | -5.80% 10-K · filed 2024-03-15 |
| 2021-12-31 | -3.00% 10-K · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |